-
-
Call more information
660-596-2224 -
ASA Monitor January 2024, Vol. 88, 8–9. Your next patient in the preoperative clinic is a 68-year-old woman scheduled to undergo an L4-5 laminectomy for chronic back pain. She had a stroke one week ago, and you are considering how long to delay this elective surgery. A recent study of older adult patients showed the risk […]
Read MoreAuthors: Matthew T. Popovich, PhD et al ASA Monitor January 2024, Vol. 88, 28–29. Although anesthesiologists have always paid attention to blood pressure and its effects on both immediate and postoperative patient outcomes, only recently have anesthesiologists had better definitions and criteria to assess management of a patient’s blood pressure. The question for anesthesiologists and their […]
Read MoreAuthor: Patsy Newitt Becker’s ASC Review For ASCs, providing anesthesia in 2023 was a huge obstacle amid provider shortages and declining reimbursements. “Today’s shortage of anesthesia providers has been compounding for years and has turned into an incredible challenge for all,” Andrew Lovewell, CEO of Columbia (Mo.) Orthopaedic Group, told Becker’s. “Not only is it difficult to […]
Read MoreNew treatment for rare blood cancer The U.S. Food and Drug Administration (FDA) has approved Tibsovo (ivosidenib) for the treatment of adult patients with relapsed or refractory myelodysplastic syndromes (MDS) who have an isocitrate dehydrogenase-1 (IDH1) mutation. MDS is a rare form of blood cancer caused by mutations in bone marrow cells, leading to a […]
Read MoreAuthors: Zachariah P.G. Olufs, B.S. et al Anesthesiology December 2023. Background Carriers of mutations in the mitochondrial electron transport chain (mETC) are at increased risk of anesthetic-induced neurotoxicity. To investigate the neurotoxicity mechanism and to test preconditioning as a protective strategy, we used a Drosophila melanogaster model of Leigh syndrome. Model flies carried a mutation in ND23 (ND2360114) that encodes […]
Read More